Ultrasound-guided vs. fluoroscopy-guided percutaneous leverage reduction for severely displaced radial neck fractures in children: a comparative analysis of clinical and radiological outcomes

超声引导与透视引导下经皮杠杆复位治疗儿童严重移位桡骨颈骨折:临床及影像学结果的比较分析

阅读:1

Abstract

BACKGROUND: Ultrasound (US) is a promising alternative to fluoroscopy (FL) for guiding percutaneous leverage reduction of displaced radial neck fractures in children. However, few studies have compared these modalities. This study aims to compare both the accuracy and efficacy of FL-guided versus US-guided percutaneous pinning in the treatment of radial neck fracture. METHODS: Seventy-three children with displaced radial neck fractures were consecutively enrolled and assigned to the US or FL group. In all the patients, fractures were reduced with the percutaneous pin leverage technique. The patients were divided into two groups: the FL-guided group and the US-guided group. Baseline information, radiographs, and clinical results according to the criteria suggested by Metaizeau and complications were analyzed. Final Metaizeau criteria were categorized into excellent, good, fair, and poor. RESULTS: The success rates for closed reduction were 100% for the US group and 91.2% for the FL group. The US group exhibited a significantly shorter operation time compared to the FL group (24.77 ± 8.00 min vs. 42.21 ± 15.18 min; P < 0.01). Additionally, the US group had a significantly lower number of FL images and radiation dose (3.59 ± 1.57 times, 9.56 ± 6.08 mGy) than the FL group (22.26 ± 8.07 times, 69.68 ± 34.70 mGy; P < 0.001). Reduction quality did not significantly differ between the groups according to the Metaizeau reduction classification (P = 0.130). According to the Metaizeau classification criteria, there was no significant difference between the two groups, including post-operative complications. CONCLUSION: Ultrasound-guided techniques offer a viable alternative for the treatment of displaced radial neck fractures in paediatric patients by minimising radiation exposure, expediting operative time and facilitating reduction. LEVEL OF EVIDENCE: Therapeutic Level III.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。